CONMED Corporation (CNMD)
NYSE • Healthcare
Last close at October 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, CONMED Corporation keeps $7 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 28
in 18 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
CONMED Corporation beat consensus on both revenue and adjusted EPS in the second fiscal quarter of 2026, reported July 29, as revenue of about $343.5 million topped the $337.6 million estimate by 1.7% and adjusted EPS of $1.38 beat the $1.10 estimate by 25.5%. Revenue was up about 0% from $343.0 million a year ago, with the largest line item, Goods transferred at a point in time, contributing about $328.1 million, roughly flat year over year, and revenue remained concentrated in the United States at about $175.4 million, down 8%. Operating income came to about $36.4 million, with gross margin near 58% and operating margin about 11%, while net income increased roughly 8% to $23.1 million from $21.4 million a year earlier. Operating cash flow was $37.1 million, and the company repurchased $6.2 million of stock. Consensus for the next period calls for EPS of $1.03 on revenue of $334.9 million.
Next report — what to expect
CONMED Corporation (CNMD) is set to report earnings on October 28, 2026. Wall Street’s consensus calls for EPS of $1.00 on revenue of $336.3 million. For trailing context, revenue rose +0.1% year over year last quarter. CNMD has beaten EPS in 8 of its 8 most recent quarters.
About CONMED Corporation
CONMED Corporation is a medical technology company in the healthcare sector that develops and sells surgical devices and related equipment for hospitals and surgical centers worldwide. Listed on the NYSE under CNMD, it generated $1.4 billion of revenue in FY2025 through a portfolio spanning orthopedics, general surgery, endoscopy, and patient monitoring.
Today's Snapshot
CNMD closed 1.6% lower at 44.40, against a firmer sector. Analysts put CONMED’s average price target at $41.40.
Trading Volume
Below 10d avg (344.1K)
288.8K
vs S&P 500 Today
Underperforming Market
-2.16%
Updated: October 9, 2026 at 20:12 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$43.07 - $45.96Sell
- RSI (14)40.86Neutral
- Stochastic %K (14, 3, 3)14.41Buy
- MACD Level (12, 26)-0.65Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.